,
your personalized virtual assistant to find clinical trials. Go head, 
Jose Lutzky, MD
Mount Sinai Medical Center CCOPMiami Beach, Florida - 33140 (305-535-3350) Mount Sinai Comprehensive Cancer Center ...Miami Beach, Florida - 33140 (305-535-3305) CCOP - Mount Sinai Medical ...Miami Beach, Florida - 33140 (305-535-3310) Mount Sinai Comprehensive Cancer CenterMiami Beach, Florida - 33140 |
- CLINICAL TRIALS 6
- CONDITIONS8
- INTERVENTIONS19
- SINCE2006
Efficacy and Safety Study of OncoVEXGM-CSF Compared to GM-CSF in Melanoma
April 2009 - June 2012
Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
April 2007 - April 2010
Temozolomide or MEK Inhibitor AZD6244 in Treating Patients With Metastatic Melanoma of the Eye
June 2010 - June 2012
Melphalan Prednisone and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
February 2008 - August 2009
Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
March 2006 - July 2007
Study of XL184 in Adults With Advanced Malignancies
August 2009 - July 2011
Lymphoma
Lymphoma, Non-Hodgkin
Multiple Myeloma
Neoplasms, Plasma Cell
Neoplasms
Melanoma
Lymphoma, Follicular
Eye Neoplasms
Placebo
Melphalan
Immunohistochemistry Staining Method
Laboratory Biomarker Analysis
Biopsy
Rituximab
Gene Expression Analysis
Prednisone
Gm-Csf
Lenalidomide
Temozolomide
Protein Expression Analysis
Oncovexgm-Csf
Thalidomide
Mutation Analysis
Imatinib Mesylate
Comparative Genomic Hybridization
Xl184
Selumetinib
